Technology area: Biotechnology & Pharmaceuticals
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 3 patents granted in the last 365 days
UNIVERSIDADE DO MINHO currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. These 3 actions are spread across 3 distinct art units, indicating a broad technological footprint within the biotech sector. This variety in art units suggests that the university is pursuing diverse research and development paths that fall under different examination categories.
The prosecution of these applications is handled by 3 distinct examiners, with no single examiner managing more than one action. This relationship between examiners and pending actions means that the university must coordinate with 3 different individuals, each with their own examination style. The presence of 3 distinct examiners across 3 distinct art units highlights the decentralized nature of the current pending portfolio.
MEYERS, ELIZABETH ANNE is the busiest examiner for the university, holding 1 busiest examiner pending action. This examiner is responsible for 1 of the 3 total pending office actions. Because the workload is distributed, the university's overall prosecution progress is influenced by the independent actions of 3 different examiners rather than a single primary contact.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 2 (67%) |
| Multi-statute (no §101) | 1 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MEYERS, ELIZABETH ANNE | 1 | 23.5% | +92.9% |
| PRAGANI, RAJAN | 1 | 53.3% | +70.0% |
| KONOPELSKI SNAVEL, SARA ELIZABETH | 1 | 33.3% | +38.9% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252712 | EUTECTIC COMPOSITIONS, METHODS AND USES THEREOF | MEYERS, ELIZABETH ANNE | 93d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18252712 | EUTECTIC COMPOSITIONS, METHODS AND USES THEREOF | MEYERS, ELIZABETH ANNE | 93d overdue |
| 17607714 | METHOD FOR PRODUCTION OF LIPOSOMES | KONOPELSKI SNAVEL, SARA ELIZABETH | 46d overdue |
| 18003129 | COMPOSITION FOR HAIR FOLLICLE MODULATION, METHODS AND USES THEREOF | PRAGANI, RAJAN | — |
| Art Unit | Apps |
|---|---|
| 1617 | 1 |
| 1614 | 1 |
| 1658 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18252712 | EUTECTIC COMPOSITIONS, METHODS AND USES THEREOF | MEYERS, ELIZABETH ANNE | 1617 | §103§112 | Final Rejection | 93d overdue | Pending | May 11, 2023 |
| 18003129 | COMPOSITION FOR HAIR FOLLICLE MODULATION, METHODS AND USES THEREOF | PRAGANI, RAJAN | 1614 | §103 | Final Rejection | — | Pending | Dec 22, 2022 |
| 17607714 | METHOD FOR PRODUCTION OF LIPOSOMES | KONOPELSKI SNAVEL, SARA ELIZABETH | 1658 | §103 | Final Rejection | 46d overdue | Pending | Oct 29, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial